featured
Comparison of Panretinal Photocoagulation and Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
JAMA Ophthalmol 2018 Jul 24;[EPub Ahead of Print], JG Gross, AR Glassman, D Liu, JK Sun, AN Antoszyk, CW Baker, NM Bressler, MJ Elman, FL Ferris, TW Gardner, LM Jampol, DF Martin, M Melia, CR Stockdale, RW BeckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.